|
End-of-day quote
Buenos Aires S.E.
10/09/2026
|
5-day change | 1st Jan Change | ||
| 155.00 ARS | +0.65% |
|
-1.59% | -35.55% |
| Market Cap | 660.14Cr 43.65L 37.54L 35.42L 32.26L 60.31L 42Cr 60.86L 4.22Cr 1.62Cr 21Cr 1.64Cr 1.6Cr 67Cr | P/E 2024 |
-3.67x | P/E 2025 | -2.23x |
|---|---|---|---|---|---|
| Enterprise Value | 733.91Cr 48.52L 41.73L 39.37L 35.87L 67.05L 46Cr 67.66L 4.69Cr 1.8Cr 24Cr 1.82Cr 1.78Cr 75Cr | EV / Sales 2024 |
0.73x | EV / Sales 2025 | 1.71x |
| Free-Float |
19.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.65% | ||
| 1 week | -1.59% | ||
| Current month | -4.32% | ||
| 1 month | -3.73% | ||
| 3 months | -4.02% | ||
| 6 months | -28.24% | ||
| Current year | -35.55% |
| 1 week | 152 |  | 161.5 |
| 1 month | 150 | | 165 |
| Current year | 128.5 | | 260 |
| 1 year | 116 | | 357 |
| 3 years | 29.2 | | 450 |
| 5 years | 9.1 | | 450 |
| 10 years | 4.2 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oscar Echeverria
DFI | Director of Finance/CFO | - | 30/07/2010 |
Federico Hoffman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eduardo Busto
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/07/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.65% | -1.59% | -15.76% | +453.57% | 43.32L | |
| -0.61% | -4.50% | -51.24% | -60.78% | 3.03TCr | |
| -2.93% | -6.39% | +24.71% | +97.24% | 1.18TCr | |
| -2.46% | +4.93% | -10.83% | +6.59% | 410.77Cr | |
| -1.95% | -5.92% | -7.08% | +13.75% | 299.87Cr | |
| -1.31% | -2.27% | +47.91% | +31.58% | 198.14Cr | |
| -0.44% | -1.16% | +10.68% | +18.34% | 189.32Cr | |
| -0.60% | -5.18% | -11.17% | +191.01% | 149.41Cr | |
| -0.78% | +3.24% | -17.19% | -1.22% | 121.53Cr | |
| -1.82% | +4.16% | -5.14% | -38.67% | 108.65Cr | |
| Average | -1.22% | -2.19% | -3.51% | +71.14% | 568.41Cr | |
| Weighted average by Cap. | -1.34% | -4.09% | -22.08% | -5.06% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 827.49Cr 54.71L 47.05L 44.39L 40.44L 75.6L 52Cr 76.29L 5.29Cr 2.03Cr 27Cr 2.05Cr 2.01Cr 84Cr | 640.36Cr 42.34L 36.41L 34.35L 31.3L 58.5L 40Cr 59.04L 4.09Cr 1.57Cr 21Cr 1.59Cr 1.56Cr 65Cr |
| Net income | -141.73Cr -9L -8L -8L -7L -12.95L -8.96Cr -13.07L -90.56L -34.85L -4.54Cr -35.19L -34.42L -14Cr | -459.77Cr -30.4L -26.14L -24.67L -22.47L -42.01L -29Cr -42.39L -2.94Cr -1.13Cr -15Cr -1.14Cr -1.12Cr -47Cr |
| Net Debt | 86Cr 6L 5L 5L 4L 8L 5.46Cr 8L 55.15L 21.23L 2.77Cr 21.43L 20.96L 8.79Cr | 74Cr 5L 4L 4L 4L 7L 4.66Cr 7L 47.14L 18.14L 2.37Cr 18.32L 17.92L 7.51Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | ARS 155.00 | +0.65% | 8,234 |
| 09/26/09 | ARS 154.00 | 0.00% | 6,213 |
| 08/26/08 | ARS 154.00 | -1.60% | 4,267 |
| 07/26/07 | ARS 156.50 | -0.32% | 2,611 |
| 04/26/04 | ARS 157.00 | -0.32% | 12,828 |
- Stock Market
- Stocks
- ROSE Stock
Select your edition
All financial news and data tailored to specific country editions
